NeuroScientific Biopharmaceuticals Limited

CHIA:NSB Stock Report

Market Cap: AU$6.2m

NeuroScientific Biopharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure2.8yrs

Recent management updates

Recent updates


CEO

NeuroScientific Biopharmaceuticals has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Frank Bonner
Member of Scientific Advisory Board2.8yrsno datano data
Peter Hnik
Member of Scientific Advisory Board2.8yrsno datano data
Christopher Ntoumenopoulos
Non-Executive Chairman of the Boardless than a yearno datano data
Anthony Keating
Non-Executive Directorless than a yearno datano data
Anton Uvarov
Non-Executive Director6.7yrsAU$83.57k1.63%
A$ 101.1k
Dao-Yi Yu
Member of Scientific Advisory Board3.8yrsno datano data
Allan Kermode
Member of Scientific Advisory Board3.3yrsno datano data
Clarke Barlow
Directorless than a yearno datano data

2.8yrs

Average Tenure

54yo

Average Age

Experienced Board: NSB's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.